Tetrindole
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| PubChem CID | |
| ChemSpider |
|
| ChEBI | |
| Chemical and physical data | |
| Formula | C20H26N2 |
| Molar mass | 294.442 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s. Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.
| |||||||||||||||||||||
| |||||||||||||||||||||
|
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
| Non-specific |
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Phenethylamines (dopamine, epinephrine, norepinephrine) |
|
||||||||||
|
Tryptamines (serotonin, melatonin) |
|
||||||||||
| Histamine |
|
||||||||||